130 related articles for article (PubMed ID: 23720057)
41. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
Gisbert JP; Panés J
Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
[TBL] [Abstract][Full Text] [Related]
42. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
43. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
44. Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease.
Rosh JR; Lerer T; Markowitz J; Goli SR; Mamula P; Noe JD; Pfefferkorn MD; Kelleher KT; Griffiths AM; Kugathasan S; Keljo D; Oliva-Hemker M; Crandall W; Carvalho RS; Mack DR; Hyams JS
Am J Gastroenterol; 2009 Dec; 104(12):3042-9. PubMed ID: 19724267
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
46. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
van den Brande JM; Peppelenbosch MP; Hommes DW
Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
[No Abstract] [Full Text] [Related]
47. [Case report: periodical infliximab administration enabled closure of colostomy in fistulating perianal Crohn's disease].
Tsujikawa T; Imaeda H; Kobayashi Y; Oosaki R; Sonoda A; Senou K; Hayafuji K; Minematsu H; Ogawa A; Nakahara T; Hata K; Andoh A; Sasaki M; Saito Y; Fujiyama Y
Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):825-9. PubMed ID: 18525188
[TBL] [Abstract][Full Text] [Related]
48. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Sandborn WJ; Hanauer SB; Rutgeerts P; Fedorak RN; Lukas M; MacIntosh DG; Panaccione R; Wolf D; Kent JD; Bittle B; Li J; Pollack PF
Gut; 2007 Sep; 56(9):1232-9. PubMed ID: 17299059
[TBL] [Abstract][Full Text] [Related]
49. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
50. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection.
Dall'Amico R; Montini G; Murer L; Andreetta B; Zacchello G; Gambino A; Feltrin G; Caforio A; Tursi V; Livi U
Int J Artif Organs; 2000 Jan; 23(1):49-54. PubMed ID: 12118837
[TBL] [Abstract][Full Text] [Related]
51. [Crohn's disease affecting only vulvoperineal area].
Girszyn N; Leport J; Arnaud L; Kahn JE; Piette AM; Bletry O
Presse Med; 2007 Dec; 36(12 Pt 1):1762-5. PubMed ID: 17587537
[TBL] [Abstract][Full Text] [Related]
52. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
Niittyvuopio R; Juvonen E; Heiskanen J; Lindström V; Nihtinen A; Sahlstedt L; Volin L
Transfusion; 2018 Aug; 58(8):1973-1979. PubMed ID: 29707788
[TBL] [Abstract][Full Text] [Related]
53. Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study.
Reinisch W; Nahavandi H; Santella R; Zhang Y; Gasché C; Moser G; Waldhör T; Gangl A; Vogelsang H; Knobler R
Aliment Pharmacol Ther; 2001 Sep; 15(9):1313-22. PubMed ID: 11552901
[TBL] [Abstract][Full Text] [Related]
54. Guidelines for the treatment of Crohn's disease in children.
; Konno M; Kobayashi A; Tomomasa T; Kaneko H; Toyoda S; Nakazato Y; Nezu R; Maisawa S; Miki K
Pediatr Int; 2006 Jun; 48(3):349-52. PubMed ID: 16732811
[TBL] [Abstract][Full Text] [Related]
55. Highly destructive perianal Crohn's disease.
Shetty AK; Udall J; Schmidt-Sommerfeld E
J Natl Med Assoc; 1998 Aug; 90(8):491-2. PubMed ID: 9727293
[TBL] [Abstract][Full Text] [Related]
56. Crohn's disease of the esophagus: clinical features and outcomes.
Decker GA; Loftus EV; Pasha TM; Tremaine WJ; Sandborn WJ
Inflamm Bowel Dis; 2001 May; 7(2):113-9. PubMed ID: 11383583
[TBL] [Abstract][Full Text] [Related]
57. Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Andreu-Ullrich H
Transfus Apher Sci; 2014 Jun; 50(3):363-9. PubMed ID: 24816437
[TBL] [Abstract][Full Text] [Related]
58. Clinical spectrum of vulva metastatic Crohn's disease.
Leu S; Sun PK; Collyer J; Smidt A; Stika CS; Schlosser B; Mirowski GW; Vanagunas A; Buchman AL
Dig Dis Sci; 2009 Jul; 54(7):1565-71. PubMed ID: 19421856
[TBL] [Abstract][Full Text] [Related]
59. Case of steroid-resistant Crohn's-associated bronchiolitis in the setting of quiescent gastrointestinal disease treated with infliximab.
Chuah CS; Noble C; Leitch A
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567117
[TBL] [Abstract][Full Text] [Related]
60. Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation.
Robinson CA; Inci I; Naegeli M; Murer C; Schuurmans MM; Urosevic-Maiwald M; Schüpbach R; Weder W; Benden C
Pediatr Transplant; 2018 May; 22(3):e13145. PubMed ID: 29380491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
